Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...

Johnson & Johnson today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with human ...

FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data –– Gazyva is the only anti-CD20 monoclonal antibody to demonstrate a ...

First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line ...

It has remained mysterious for millennia, but we’re finally uncovering the profound role the lymphatic system plays in ...

When you wake up in the morning, it might feel like your brain just switched on at the ring of an alarm, although you still ...

STAT Wunderkind Sydney Ramirez is revealing the immune system in our nasal passages and working toward better disease ...

Taking a deep breath restores the ideal “layering” of lung fluids, according to a new experiment.

The Trump administration’s purge at the Centers for Disease Control and Prevention (CDC) has left employees reeling.   The firings, which began late Friday, ran across more than a dozen divisions ...

UCB, a global biopharmaceutical company, today announced that the final analysis of an open-label extension (OLE) study with ...